CD4+/CD8+ T-cell ratios after BMT
Type of BMT and treatment . | Days after BMT . | . | . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|
| . | 14 . | 28 . | 42 . | 56 . | 63 . | ||||
| T-cell-replete | |||||||||
| IL-7 | 2.7 | 2.8 | 1.7 | 1.1 | 1.0 | ||||
| PBS | 2.0 | 1.4 | 1.5 | 1.2 | 0.7 | ||||
| TCD | |||||||||
| IL-7 | — | — | 1.0 | 1.9 | 3.1 | ||||
| PBS | — | — | 1.3 | 1.5 | 1.9 | ||||
Type of BMT and treatment . | Days after BMT . | . | . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|
| . | 14 . | 28 . | 42 . | 56 . | 63 . | ||||
| T-cell-replete | |||||||||
| IL-7 | 2.7 | 2.8 | 1.7 | 1.1 | 1.0 | ||||
| PBS | 2.0 | 1.4 | 1.5 | 1.2 | 0.7 | ||||
| TCD | |||||||||
| IL-7 | — | — | 1.0 | 1.9 | 3.1 | ||||
| PBS | — | — | 1.3 | 1.5 | 1.9 | ||||
Shown are ratios of absolute median numbers of peripheral blood CD3+CD4+ and CD3+CD8+ T cells/μL per group of mice (n = 6). — indicates not applicable.